Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D Friedman

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|March 17, 2017
RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AMLR Katherine Hyde, Paul Liu, Alan D Friedman
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokine-induced neutrophil productionDehua Wang, Ido Paz-Priel, Alan D Friedman
Oncogene|January 23, 2004
C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA bindingRebecca Cleaves, Qian-fei Wang, Alan D Friedman
Blood|July 10, 2009
M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specificationGraham D Jack, Li Zhang, Alan D Friedman
Cancer Immunology, Immunotherapy : CII|February 4, 2025
PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progenyMohammad A Alzubi, Theresa Barberi, Alan D Friedman
Molecular Oncology|January 22, 2021
Adoptive transfer of immature myeloid cells lacking NF-κB p50 (p50-IMC) impedes the growth of MHC-matched high-risk neuroblastomaCheng Cui, Theresa Barberi, Rahul Suresh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 2018
Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBPαHong Guo, Theresa Barberi, Rahul Suresh, et al.
Cancer Biology & Therapy|December 24, 2002
c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoproteinFlorence Bernardin, Yandan Yang, Curt I Civin, et al.
Blood|February 25, 2011
C/EBPα and C/EBPα oncoproteins regulate nfkb1 and displace histone deacetylases from NF-κB p50 homodimers to induce NF-κB target genesIdo Paz-Priel, Simone Houng, Julia Dooher, et al.
Blood|November 16, 2007
Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferationLinsheng Zhang, Florence B Fried, Hong Guo, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|March 17, 2017
RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AMLR Katherine Hyde, Paul Liu, Alan D Friedman
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokine-induced neutrophil productionDehua Wang, Ido Paz-Priel, Alan D Friedman
Oncogene|January 23, 2004
C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA bindingRebecca Cleaves, Qian-fei Wang, Alan D Friedman
Blood|July 10, 2009
M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specificationGraham D Jack, Li Zhang, Alan D Friedman
Cancer Immunology, Immunotherapy : CII|February 4, 2025
PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progenyMohammad A Alzubi, Theresa Barberi, Alan D Friedman
Molecular Oncology|January 22, 2021
Adoptive transfer of immature myeloid cells lacking NF-κB p50 (p50-IMC) impedes the growth of MHC-matched high-risk neuroblastomaCheng Cui, Theresa Barberi, Rahul Suresh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 2018
Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBPαHong Guo, Theresa Barberi, Rahul Suresh, et al.
Cancer Biology & Therapy|December 24, 2002
c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoproteinFlorence Bernardin, Yandan Yang, Curt I Civin, et al.
Blood|February 25, 2011
C/EBPα and C/EBPα oncoproteins regulate nfkb1 and displace histone deacetylases from NF-κB p50 homodimers to induce NF-κB target genesIdo Paz-Priel, Simone Houng, Julia Dooher, et al.
Blood|November 16, 2007
Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferationLinsheng Zhang, Florence B Fried, Hong Guo, et al.
Pageof 7